Found 7 matching trials
Extension Study of Participants From SPG302-ALS-001
PHASE2This study will evaluate the long-term safety and efficacy of participants ...
Location
Macquarie University
Study of SPG302 in Adults With Schizophrenia
PHASE2This Phase 2 study described herein will evaluate the safety, efficacy, tol...
Status
Active Not Recruiting
Efficacy and Safety of Tazbentetol in ALS Participants
PHASE2The objectives of this study are to examine the effects of tazbentetol on c...
Location
Multiple Locations
Study of SPG302 in Healthy Volunteers and ALS Participants
PHASE1The first-in-human Phase 1 study described herein will evaluate the safety,...
Location
Macquarie University
Study of SPG302 in Adult Participants With Mild-to-Moderate Alzheimer's Disease (AD)
PHASE2This phase 2 study will evaluate the safety, tolerability, clinical efficac...
Status
Active Not Recruiting
Location
St Vincent's Hospital
Intermediate-size Patient Population Expanded Access Protocol
N/AThe purpose of this Expanded Access Program is to provide tazbentetol to AL...
Location
University of Alabama Birmingham
Extension Study of Participants From SPG302-ALZ-101
PHASE2This study will evaluate the long-term safety and efficacy of participants ...
Location
St. Vincent's Hospital